Actively Recruiting

Phase 2
Age: 18Years - 75Years
All Genders
NCT07108777

L-Carnitine Protective Effect in Nephrotoxicity

Led by Tanta University · Updated on 2025-08-12

46

Participants Needed

1

Research Sites

64 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

The goal of this clinical trial is to assess the possible reno-protective effect of L-carnitine against cisplatin-induced nephrotoxicity in patients receiving cisplatin-based chemotherapy. The main question it aims to answer is: Does L-carnitine have the ability to protect the kidney against cisplatin-induced nephrotoxicity?

CONDITIONS

Official Title

L-Carnitine Protective Effect in Nephrotoxicity

Who Can Participate

Age: 18Years - 75Years
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Male or female patients
  • Newly diagnosed with cancer and scheduled for cisplatin-based chemotherapy
  • Aged between 18 and 75 years
  • No serious heart or lung conditions that affect study participation
  • Creatinine clearance above 50 mL/min/1.73 m²
  • Scheduled to receive at least 3 cycles of cisplatin
  • No previous kidney diseases, including acute nephropathy or renal failure
Not Eligible

You will not qualify if you...

  • Pregnancy or breastfeeding
  • Metastasis to the central nervous system
  • Psychiatric disorders
  • Prior treatment with platinum-based chemotherapy
  • Allergy to cisplatin, carboplatin, or other platinum drugs
  • Active infection or signs of sepsis
  • Acute kidney failure or kidney surgery within the last 3 months
  • Unfit for cisplatin due to kidney problems, hearing loss, or heart muscle disease
  • History of or current treatment with kidney-damaging drugs
  • Taking antioxidant supplements like Vitamins C or E

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Menoufia Clinical Oncology Department, Menoufia University.

Shibīn al Kawm, Egypt

Actively Recruiting

Loading map...

Research Team

F

Fatma M Eweda, Master

CONTACT

F

Fatma M Eweda

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

PREVENTION

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here